Michael Alfano - Dentsply Sirona Independent Director

XRAY Stock  USD 30.92  0.06  0.19%   

Director

Dr. Michael C. Alfano, Ph.D., is an Independent Director of the Company. Dr. Alfano is Executive Vice President Emeritus, and Professor and Dean Emeritus at New York University . Dr. Alfano served as Dean of the College of Dentistry from 1998 to 2006 and as Executive VicePresident of NYU from 2006 to 2013. Beginning in 1982 until 1998 he held a number of positions with Block Drug Company, including Senior Vice President for Research Technology and President of Block Professional Dental Products Company. He served on the Board of Directors of Block Drug Company, Inc. from 1988 to 1998. Dr. Alfano has served as a member of, or consultant to, various public health organizations, including the National Institutes of Health, the Editorial Board of the American Journal of Dentistry, the Consumer Healthcare Product Association and as the industry representative to the NonPrescription Drugs Advisory Committee of the FDA from 2001 to 2005. He was a founding director of the Friends of the National Institute for Dental and Craniofacial Research, and he is a founding director of the notforprofit Santa Fe Group. He was also a Trustee of the New York State Dental Foundation until 2006. From 20102015 he served as a director of the notforprofit Delta Dental of New York Insurance Company. He also served as a Director of the YMCA of Greater New York, the largest YMCA system in the country, from 2010 to 2014. Dr. Alfano has had a distinguished career as a researcher. He served as Professor, Dean of Dentistry and Executive Vice President of New York University for 16 years, and for more than a decade, he was Chief Technology Officer of the Block Drug Company. since 2001.
Age 70
Tenure 23 years
Professional MarksPh.D
Address 13320-B Ballantyne Corporate Place, Charlotte, NC, United States, 28277-3607
Phone844 848 0137
Webhttps://www.dentsplysirona.com
Alfano served as Dean of the College of Dentistry from 1998 to 2006, and as Executive VicePresident of NYU from 2006 to 2013. Beginning in 1982 until 1998 he held a number of positions with Block Drug Company, including Senior Vice President for Research & Technology and President of Block Professional Dental Products Company. He served on the Board of Directors of Block Drug Company, Inc. from 1988 to 1998. He has served as a member of, or consultant to, various public health organizations, including the Editorial Board of the American Journal of Dentistry since 1987, the Consumer Healthcare Product Association and as the industry representative to the NonPrescription Drugs Advisory Committee of the FDA from 2001 to 2005. He is a founding director of the Friends of the National Institute for Dental and Craniofacial Research, and he is a founding director of the notforprofit Santa Fe Group. He was also a Trustee of the New York State Dental Foundation until 2006. In 2010, Dr

Dentsply Sirona Management Efficiency

The company has return on total asset (ROA) of 0.0241 % which means that it generated a profit of $0.0241 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0372) %, meaning that it created substantial loss on money invested by shareholders. Dentsply Sirona's management efficiency ratios could be used to measure how well Dentsply Sirona manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.04 in 2024. Return On Capital Employed is likely to drop to 0.05 in 2024. At this time, Dentsply Sirona's Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 271.9 M in 2024, whereas Total Assets are likely to drop slightly above 3.7 B in 2024.
The company currently holds 2.3 B in liabilities with Debt to Equity (D/E) ratio of 0.6, which is about average as compared to similar companies. Dentsply Sirona has a current ratio of 1.47, which is within standard range for the sector. Debt can assist Dentsply Sirona until it has trouble settling it off, either with new capital or with free cash flow. So, Dentsply Sirona's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Dentsply Sirona sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Dentsply to invest in growth at high rates of return. When we think about Dentsply Sirona's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Mark KrollHaemonetics
67
Sally CrawfordHologic
64
Carlos ToledoAlcon AG
N/A
Luis HueteAlcon AG
N/A
Fidel HidalgoAlcon AG
N/A
Malcolm PradhanAlcon AG
N/A
Steven RosenbergThe Cooper Companies
55
James OrrBecton Dickinson and
70
John WeilandWest Pharmaceutical Services
61
Christopher RobertsResMed Inc
60
Patricia BarronTeleflex Incorporated
73
Thomas GundersonMerit Medical Systems
66
Ron TaylorResMed Inc
67
Joseph SaucedoICU Medical
73
Nathan BuzzaAlcon AG
N/A
Brian LeedmanAlcon AG
N/A
David LiuMerit Medical Systems
43
Wesley JohnsonAngioDynamics
59
Harjit GillResMed Inc
55
Richard EdelmanMerit Medical Systems
73
Elaine UllianHologic
68
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company was founded in 1877 and is headquartered in Charlotte, North Carolina. Dentsply Sirona operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 15000 people. Dentsply Sirona (XRAY) is traded on NASDAQ Exchange in USA. It is located in 13320-B Ballantyne Corporate Place, Charlotte, NC, United States, 28277-3607 and employs 15,000 people. Dentsply Sirona is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Dentsply Sirona Leadership Team

Elected by the shareholders, the Dentsply Sirona's board of directors comprises two types of representatives: Dentsply Sirona inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dentsply. The board's role is to monitor Dentsply Sirona's management team and ensure that shareholders' interests are well served. Dentsply Sirona's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dentsply Sirona's outside directors are responsible for providing unbiased perspectives on the board's policies.
Maureen MacInnis, Chief Human Resource Officer, Senior Vice President
Dan Workinger, Treasurer
Thomas Jetter, Lead Director, Independent Director
Paula Cholmondeley, Independent Director
Lisa Yankie, VP Officer
Francis Lunger, Independent Director
Andrew Robinson, VP Officer
Kevin Boyle, Senior Officer
Christopher Clark, Pres and CFO
Deborah Rasin, Vice President General Counsel, Secretary
Betsy Holden, Director
Donald Casey, CEO, Director
Derek Leckow, VP, Investor Relations
Andreas Frank, Executive Officer
Nicholas Alexos, Executive Vice President Chief Administrative Officer
Daniel Key, Senior Vice President Chief Supply Chain Officer
Justin McCarthy, General Counsel, Secretary
Albert Sterkenburg, Senior Vice President
Markus Boehringer, Senior Vice President - EMEA RCO
Erania Brackett, SVP Sustainability
Walter Petersohn, Senior Vice President Chief Commercial Officer
William Hecht, Lead Independent Director
Jonathan Friedman, Senior Vice President General Counsel, Secretary
Mark Thierer, Interim CEO
Cord Staehler, VP CTO
Bret Wise, Chairman, CEO and Chairman of Executive Committee
Glenn Coleman, Executive CFO
Henning Mueller, Group Vice President - Asia Pacific RCO
Ulrich Michel, CFO, Executive Vice President
Rainer Berthan, Executive Vice President Manufacturing and Supply Chain
Richard Wagner, Chief Officer
Cheree Johnson, Chief VP
Dane Baumgardner, AttorneyInFact
John Sweeney, vice president IR Contact Officer
Eric Bruno, Senior Vice President - North America Regional Commercial Organization
Jorge Gomez, CFO, Executive Vice President
Andrea Daley, Vice Relations
Robert Size, Sr. VP
Harry Kraemer, Director
Andrea Frohning, Senior Officer
Michael Coleman, Independent Director
David Beecken, Director
Leslie Varon, Director
Eric Brandt, Independent Director
Robert Johnson, Senior Officer
William Newell, Senior Vice President Chief Segment Officer
Willie Deese, Independent Director
Simon Campion, President CEO
Keith Ebling, Executive Vice President General Counsel, Secretary
John Miles, Independent Director
Richard Rosenzweig, General Development
Michael Alfano, Independent Director
James Mosch, COO and Executive VP
Emily Miner, Senior Officer
John Miclot, Independent Director
Arthur Kowaloff, Director
Jeffrey Slovin, CEO, Director

Dentsply Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dentsply Sirona a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Dentsply Sirona Investors Sentiment

The influence of Dentsply Sirona's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Dentsply. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Dentsply Sirona's public news can be used to forecast risks associated with an investment in Dentsply. The trend in average sentiment can be used to explain how an investor holding Dentsply can time the market purely based on public headlines and social activities around Dentsply Sirona. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Dentsply Sirona's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Dentsply Sirona's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Dentsply Sirona's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Dentsply Sirona.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dentsply Sirona in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dentsply Sirona's short interest history, or implied volatility extrapolated from Dentsply Sirona options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Dentsply Sirona offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dentsply Sirona's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dentsply Sirona Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dentsply Sirona Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Dentsply Sirona. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Dentsply Stock please use our How to Invest in Dentsply Sirona guide.
Note that the Dentsply Sirona information on this page should be used as a complementary analysis to other Dentsply Sirona's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Dentsply Stock analysis

When running Dentsply Sirona's price analysis, check to measure Dentsply Sirona's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dentsply Sirona is operating at the current time. Most of Dentsply Sirona's value examination focuses on studying past and present price action to predict the probability of Dentsply Sirona's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dentsply Sirona's price. Additionally, you may evaluate how the addition of Dentsply Sirona to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Is Dentsply Sirona's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dentsply Sirona. If investors know Dentsply will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dentsply Sirona listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.178
Dividend Share
0.56
Earnings Share
(0.62)
Revenue Per Share
18.703
Quarterly Revenue Growth
0.03
The market value of Dentsply Sirona is measured differently than its book value, which is the value of Dentsply that is recorded on the company's balance sheet. Investors also form their own opinion of Dentsply Sirona's value that differs from its market value or its book value, called intrinsic value, which is Dentsply Sirona's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dentsply Sirona's market value can be influenced by many factors that don't directly affect Dentsply Sirona's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dentsply Sirona's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dentsply Sirona is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dentsply Sirona's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.